|
FI800396A
|
|
Foerfarande foer framstaellning av antiinflammatoriska orgoteinderivat
|
|
ATA876078A
|
|
Method for producing injectable orgotine derivatives
|
|
US4073897A
|
|
Treatment of arthritis and allied conditions with xenylsalate
|
|
JPS5233700A
|
|
Production of olgotein derivative
|
|
IL50287D0
|
|
Alkylated,carbamylated or esterified orgotein derivatives,their production and pharmaceutical compositions containing them
|
|
JPS5285104A
|
|
Nnacylorgotein
|
|
US4070459A
|
|
N-carbamylated orgotein
|
|
US4042689A
|
|
Alkylated orgotein
|
|
US4009267A
|
|
Cross-linked orgotein
|
|
US4022224A
|
|
Reduction of superoxide accumulation caused by smoke inhalation
|
|
US4022888A
|
|
Esterified orgotein
|
|
US4022877A
|
|
Radioactive labeled orgotein
|
|
AU8278075A
|
|
Orgotein purification process
|
|
KR790000029B1
|
|
Isolation of orgotein
|
|
US4017605A
|
|
Acylated orgotein
|
|
KR790000054B1
|
|
Isolation of orgotein
|
|
US3832338A
|
|
Orgotein production using a buffer solution containing divalent metal salts
|
|
BE792290A
|
|
Orgatein isolation - using protidolytic enzymes, thermic degradation and chromatography
|
|
ES409308A1
|
|
A procedure for the insulation of orgotein of a mixture of soluble proteins. (Machine-translation by Google Translate, not legally binding)
|
|
IL40955D0
|
|
The production of orgotein from red blood cells
|
